IPF Summit 2022

During the IPF Summit, APIE Therapeutics presented a poster describing the novel apelin receptor agonist (APT101) and its effects in models of acute and chronic lung injury
Title: Vascular Endothelium Repair and Regeneration as Target of Novel Small Molecule Anti-fibrotic and Anti-inflammatory Agent for the Treatment of Lung Fibrosis
Authors: Willette RN1, Runyon S2, Maitra R2, Alegria E1
Date/Time: August 30, 2022 at 3:30 pm ET

1) APIE-Therapeutics Inc. 2) Research Triangle Park